Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Fadalla, Kamal"'
Publikováno v:
Case Reports in Hematology.
Acquired resistance to tyrosine kinase inhibitors (TKIs) remains a therapeutic challenge in the treatment of chronic myeloid leukemia (CML). The most studied reason for TKI resistance is the acquisition of mutations within the BCR::ABL1 tyrosine kina
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nic Dhonncha, Eilis1 (AUTHOR) e.nicdhonncha1@gmail.com, Fadalla, Kamal2 (AUTHOR), Moriarty, Blaithin1 (AUTHOR), Gibbons, David3 (AUTHOR), Collins, Conor D.4 (AUTHOR), Fabre, Aurelie3 (AUTHOR), Collins, Paul1 (AUTHOR)
Publikováno v:
Journal of Dermatological Treatment. Dec2017, Vol. 28 Issue 8, p764-765. 2p.
Publikováno v:
Case Reports in Hematology; 2023, Vol. 2023 Issue: 1
Autor:
Elyamany, Ghaleb, Awad, Mohammad, Fadalla, Kamal, Albalawi, Mohamed, Al Shahrani, Mohammad, Al Abdulaaly, Abdulaziz
Publikováno v:
Advances in Hematology; 2014, p1-7, 7p
Autor:
Langabeer, Stephen E., Crampe, Mireille, Kelly, Johanna, Fadalla, Kamal, Connaghan, Gerard, Conneally, Eibhlin
Publikováno v:
In Leukemia Research 2010 34(8):e204-e205
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elyamany G; Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. ; Department of Hematology and Blood Bank, Theodor Bilharz Research Institute, Giza, Egypt., Fadalla K; Department of Adult Clinical Hematology and Stem cell Therapy, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia., Elghezal H; Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Alsuhaibani O; Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Osman H; Department of Adult Clinical Hematology and Stem cell Therapy, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia., Al-Abulaaly A; Department of Adult Clinical Hematology and Stem cell Therapy, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.
Publikováno v:
Clinical medicine insights. Pathology [Clin Med Insights Pathol] 2014 Sep 23; Vol. 7, pp. 21-7. Date of Electronic Publication: 2014 Sep 23 (Print Publication: 2014).
Autor:
Elyamany G; Department of Hematology and Blood Bank, Theodor Bilharz Research Institute. ; Dept. of Central Military Laboratory, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Awad M; Dept. of Central Military Laboratory, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Alsuhaibani O; Dept. of Central Military Laboratory, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Fadalla K; Dept. of Adult Clinical Hematology and Stem cell Therapy, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Al Sharif O; Dept. of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Al Shahrani M; Dept. of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Alabbas F; Dept. of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Al-Abulaaly A; Dept. of Adult Clinical Hematology and Stem cell Therapy, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Publikováno v:
Mediterranean journal of hematology and infectious diseases [Mediterr J Hematol Infect Dis] 2014 Jun 01; Vol. 6 (1), pp. e2014038. Date of Electronic Publication: 2014 Jun 01 (Print Publication: 2014).